About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
How to Identify, Treat, and Manage Patients with Multiple Myeloma
How to Identify, Treat, and Manage Patients with Multiple Myeloma
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
K
Moffitt Cancer Center Debate: How Much Is Enough in NDMM - Triplet Therapy vs. Quadruplet Therapy
By
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
FEATURING
Kenneth Shain
By
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
FEATURING
Kenneth Shain
150 views
February 14, 2022
0 Comments
Login to view comments.
Click here to Login
How to Identify, Treat, and Manage Patients with Multiple Myeloma
05:27
ASH 2021 Conference Coverage on VuMedi
ASH 2021 Sustained Improvement in HRQoL in Transplant-Ineligible Pat…
Feat.
A. Perrot
08:55
Laurent Garderet
D-Rd in Transplant-Ineligible NDMM: Results From the MAIA Trial
16:16
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
Frontline Therapy for NDMM: The Role of Transplant, Duration & G…
Feat.
A. Krishnan
15:16
SOHO 3rd Italian Conference
SOHO Italy 2021: Newly Diagnosed Transplant-Eligible MM
Feat.
V. Montefusco
09:07
ASH 2021 Conference Coverage on VuMedi
ASH 2021: Genomic and Immune Signatures Predict Sustained MRD Negati…
Feat.
E. Boyle
19:15
Total Health
Treatment Updates for MM: Risk Stratification's Role in Upfront…
Feat.
C. Gleason
18:44
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Moffitt Cancer Center Debate: How Much Is Enough in NDMM - Triplet …
Feat.
K. Shain
13:22
SOHO 3rd Italian Conference
SOHO Italy 2021 on the Importance of Imaging in Novel Agents' E…
Feat.
E. Zamagni
06:03
UChicago Medicine 7th Annual Updates from ASH 2021
Post-ASH Case Discussion: 59 y/o Male With Blurry Vision and Develop…
Feat.
S. Smith,
M. Drazer
19:18
Yale Cancer Center
2021 ASH Updates in Smoldering Myeloma and Newly Diagnosed MM
Feat.
E. Gorshein
07:15
Ola Landgren
Awareness Around MRD Testing in Myeloma: Why, When, and How to Test
20:17
Rush University Medical Center
High-Risk Myeloma: Failures and Future Directions
Feat.
S. Usmani
20:58
Penn Medicine Abramson Cancer Center
Initial Therapy for MM Including Transplant
Feat.
A. Garfall
04:29
ecancer
EHA 2022 on a Phase III GMMG-HD7 Trial: Isa-RVd as Induction Therapy…
Feat.
E. Mai
31:36
Nebraska Oncology Society
ASCO 2022 on Moving Toward a Cure in Myeloma: The Role of MRD Testing
Feat.
A. Nooka
